Poloxamer 188 Does Not Reduce Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial
JAMA 2021 Apr 20;325(15)1513-1523, JF Casella, BA Barton, J Kanter, LV Black, S Majumdar, A Inati, Y Wali, RA Drachtman, MR Abboud, Y Kilinc, BR Fuh, MK Al-Khabori, CM Takemoto, E Salman, SA Sarnaik, N Shah, CR Morris, J Keates-Baleeiro, A Raj, OA Alvarez, LL Hsu, AA Thompson, IY Sisler, BS Pace, SA Noronha, JL Lasky, EC de Julian, K Godder, CD Thornburg, NL Kamberos, R Nuss, AM Marsh, WC Owen, A Schaefer, CK Tebbi, CF Chantrain, DE Cohen, Z Karakas, CM Piccone, A George, JM Fixler, TC Singleton, T Moulton, CT Quinn, CL de Castro Lobo, AM Almomen, M Goyal-Khemka, P Maes, M Emanuele, RT Gorney, CS Padgett, E Parsley, SS Kronsberg, GJ Kato, MT GladwinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.